Genenta Science S.p.A. has 2 Schedule 13D or 13G filings on record since 2026-01-27. 2 holders' latest filing reports 5% or more of ordinary shares and american depository shares. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Marco Nuzzo | 23% | 5,433,910 | SCHEDULE 13D, 2026-05-05 | 2026-05-04 |
| Pierluigi Paracchi | 9.8% | 2,302,516 | SCHEDULE 13G/A, 2026-01-27 | 2026-01-25 |
Purpose of Transaction (Item 4)
Marco Nuzzo
The Reporting Persons intend to promote the unity and stability of the Issuer's strategic direction, including monitoring the legality of the Issuer's board of directors' actions, to the extent permitted by Italian law and the Issuer's Articles of Association. In particular, the Reporting Persons intend to (i) promote the stability of the Issuer's strategic direction within the scope and within the limits of the biotech activities as solely authorized by Article 4 ("Corporate Purpose"), paragraph 1 of the Issuer's Articles of Association in force until October 29, 2025 and to (ii) oppose, to the extent permitted by law and the Articles of Association, the addition of new activities "in all sectors covered by the Italian legislation governing the exercise of special powers (so-called "Golden Power") as in force from time to time" as a result of the resolution adopted by the Issuer's extraordinary shareholders' meeting on the aforementioned date of October 29, 2025. Such resolution amended Article 4 of the Issuer's Articles of Association by adding a new paragraph 2, containing the aforementioned generic and vague reference to all Golden Power sectors, as in force from time to time. The Reporting Persons deem such reference null and void because of its vagueness and the above mentioned October 29, 2025 extraordinary resolution (together with another previous extraordinary shareholders' meeting resolution adopted on May 2, 2024 and introducing a certain form of selective …The first part of Item 4 of the SCHEDULE 13D filed 2026-05-05; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-01-27 | Pierluigi Paracchi | 9.8% | SCHEDULE 13G/A |
| 2026-05-05 | Marco Nuzzo | 23% | SCHEDULE 13D |
Tools for this story
Each opens in a new tab, filled in for Genenta Science S.p.A.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.